NLS Acquisition

Bringwell is selling its  subsidiary NaturaMed Pharma to Volato for SEK 308 million. NaturaMed Pharma is a supplier of food supplements, pharmaceuticals and health care and athletic products sold directly to customers. The payment settlement will be made in cash and will be used to reimburse the company’s debts, meaning that Bringwell will become debt […]

H. Lundbeck A/S entered into a definitive agreement under which Lundbeck will commence a tender offer to acquire Chelsea Therapeutics International, Ltd. Under the agreement, Lundbeck will gain rights to the FDA-approved product droxidopa with expected launch during 2014. Lundbeck is offering USD 658 million. The total potential consideration represents an attractive premium of 59% over the closing […]

GlaxoSmithKline has announced a 3-part inter-conditional transaction with Novartis AG involving its Consumer Healthcare, Vaccines and Oncology businesses. The two companies will create a new consumer healthcare business with 2013 pro forma revenues of £6.5 billion. GSK will have majority control with an equity interest of 63.5%. GSK will also acquire Novartis’ global Vaccines business (excluding […]

Mediplast has acquired all shares in Kendan A/S located in Lynge, Denmark.

Red Glead Discovery in Lund has acquired Pepticon to create a company for drug discovery research services.

AstraZeneca completes purchase of Sumitomo Chemical’s stake in AstraZeneca K.K. The company announced on March 26 that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. According to a statement the purchase was valued at approximately JPY10 billion ($102 million). This gives AstraZeneca control of the entire shareholding of AstraZeneca K.K. “Our […]